| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Sight Sciences, Inc. | Chief Operating Officer | Common Stock | 599,983 | $4,487,872 | $7.48 | 06 Jan 2026 | Direct |
| Inogen Inc | EVP, Finance, & CFO | Common Stock | 33,902 | $193,919 | $5.72 | 01 Dec 2021 | Direct |
| Inogen Inc | EVP, Finance, & CFO | Restricted Stock Unit | 4,915 | $28,114 | $5.72 | 01 Dec 2021 | Direct |
| Pear Therapeutics, Inc. | Director | Class A Common Stock | 71,428 | 15 Feb 2023 | Direct | ||
| GELESIS HOLDINGS, INC. | Director | Common Stock | 51,095 | 06 May 2022 | Direct | ||
| Inogen Inc | EVP, Finance, & CFO | Stock Option (Right to Buy) | 0 | 15 Dec 2020 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SGHT | Sight Sciences, Inc. | 05 Jan 2026 | 2 | -$157,366 | 4 | Chief Operating Officer | 06 Jan 2026, 19:03 |
| SGHT | Sight Sciences, Inc. | 11 Nov 2025 | 1 | $0 | 4 | Chief Operating Officer | 13 Nov 2025, 16:35 |
| SGHT | Sight Sciences, Inc. | 02 Oct 2025 | 1 | -$65,828 | 4 | Chief Financial Officer | 03 Oct 2025, 17:53 |
| SGHT | Sight Sciences, Inc. | 02 Jul 2025 | 1 | -$78,927 | 4 | Chief Financial Officer | 07 Jul 2025, 21:27 |
| SGHT | Sight Sciences, Inc. | 19 May 2025 | 1 | -$45,430 | 4 | Chief Financial Officer | 21 May 2025, 20:38 |
| SGHT | Sight Sciences, Inc. | 02 Apr 2025 | 1 | -$44,788 | 4 | Chief Financial Officer | 03 Apr 2025, 21:54 |
| SGHT | Sight Sciences, Inc. | 11 Mar 2025 | 1 | $0 | 4 | Chief Financial Officer | 13 Mar 2025, 21:56 |
| SGHT | Sight Sciences, Inc. | 03 Jan 2025 | 1 | -$35,579 | 4 | Chief Financial Officer | 06 Jan 2025, 21:47 |
| SGHT | Sight Sciences, Inc. | 01 Oct 2024 | 1 | -$61,590 | 4 | Chief Financial Officer | 03 Oct 2024, 21:53 |
| SGHT | Sight Sciences, Inc. | 02 Jul 2024 | 1 | -$65,207 | 4 | Chief Financial Officer | 03 Jul 2024, 19:50 |
| SGHT | Sight Sciences, Inc. | 17 May 2024 | 1 | -$70,870 | 4 | Chief Financial Officer | 20 May 2024, 20:56 |
| SGHT | Sight Sciences, Inc. | 03 Apr 2024 | 1 | -$51,415 | 4 | Chief Financial Officer | 04 Apr 2024, 19:19 |
| SGHT | Sight Sciences, Inc. | 14 Feb 2024 | 1 | $0 | 4 | Chief Financial Officer | 16 Feb 2024, 21:36 |
| SGHT | Sight Sciences, Inc. | 09 May 2023 | 2 | $0 | 4 | Chief Financial Officer and Treasurer | 11 May 2023, 21:55 |
| SGHT | Sight Sciences, Inc. | 03 Apr 2023 | 0 | $0 | 3 | Exhibit list: Exhibit 24 - Power of Attorney Chief Financial Officer and Treasurer | 05 Apr 2023, 21:32 |
| PEARQ | Pear Therapeutics, Inc. | 15 Feb 2023 | 1 | $0 | 4 | Director | 17 Feb 2023, 15:09 |
| PEARQ | Pear Therapeutics, Inc. | 14 Jun 2022 | 1 | $0 | 4 | Director | 16 Jun 2022, 16:12 |
| GLSH | GELESIS HOLDINGS, INC. | 06 May 2022 | 1 | $0 | 4 | Director | 09 May 2022, 16:15 |
| GLSH | GELESIS HOLDINGS, INC. | 13 Jan 2022 | 0 | $0 | 3 | Director | 24 Jan 2022, 15:32 |
| PEARQ | Pear Therapeutics, Inc. | 08 Dec 2021 | 1 | $0 | 4 | Director | 10 Dec 2021, 15:47 |
| PEARQ | Pear Therapeutics, Inc. | 03 Dec 2021 | 1 | $0 | 4 | Director | 07 Dec 2021, 16:27 |
| PEARQ | Pear Therapeutics, Inc. | 03 Dec 2021 | 0 | $0 | 3 | Director | 07 Dec 2021, 16:09 |
| INGN | Inogen Inc | 01 Dec 2021 | 3 | -$14,533 | 4 | EVP, Finance, & CFO | 03 Dec 2021, 17:15 |
| INGN | Inogen Inc | 01 Sep 2021 | 5 | -$37,311 | 4 | EVP, Finance, & CFO | 03 Sep 2021, 18:39 |
| INGN | Inogen Inc | 30 Jul 2021 | 6 | -$399,921 | 4 | EVP, Finance, & CFO | 03 Aug 2021, 19:56 |
| INGN | Inogen Inc | 27 Jul 2021 | 3 | -$351,347 | 4 | EVP, Finance, & CFO | 29 Jul 2021, 16:15 |
| INGN | Inogen Inc | 01 Jun 2021 | 5 | -$37,049 | 4/A | EVP, Finance, & CFO | 03 Sep 2021, 18:38 |
| INGN | Inogen Inc | 15 Dec 2020 | 5 | -$204,881 | 4/A | EVP, Finance, & CFO | 03 Dec 2021, 17:10 |